UPCC 37418 Database and Biospecimen Bank for patients treated with CAR T and other immune effector-cell therapies

Enrolling By Invitation
99 years or below
All
1 Location

Brief description of study

The purpose of this research study is to collect clinical information and biologic specimens from patients receiving CAR T cells and other cancer immunotherapies. The clinical information and biologic specimens will be used to better understand how these therapies work to treat cancer and how they affect patients immune systems.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: TBD
  • Age: 99 years or below
  • Gender: All
Updated on 12 Dec 2018. Study ID: 18-0642
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator